FDA Inspection
Cton LaboratoriesCton Laboratories – FDA Inspection, Jul 25, 2025
Record Details
This FDA Inspection record concerns Cton Laboratories, with an inspection on July 25, 2025, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 025d7744-0571-4578-9127-c488612d328c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1276594
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.160(a)All core requirements covered in program
- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.270(a)Records incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cton Laboratories
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 30, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Cton Laboratories
- FDA Inspection 1076957 - 2018-11-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.